Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States
Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States
To address influenza B lineage mismatch and co-circulation, several quadrivalent inactivated influenza vaccines (IIV4s) containing two type A strains and both type B lineages have recently been approved in the United States. Currently available trivalent inactivated vaccines (IIV3s) or trivalent live attenuated influenza vaccines (LAIV3s) comprise two influenza A strains …